α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Top Cited Papers
- 31 July 2009
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 137 (1), 110-118
- https://doi.org/10.1053/j.gastro.2009.04.005
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA-084986, DK064909)
This publication has 26 references indexed in Scilit:
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Management of hepatocellular carcinomaJournal of Hepatology, 2005
- Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver massLiver Transplantation, 2005
- Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patientsJournal of Hepatology, 2003
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewJournal of Hepatology, 2002
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewJournal of Hepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001
- Utility of lentil lectin affinity of α-fetoprotein in the diagnosis of hepatocellular carcinomaJournal of Hepatology, 1996
- A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patientsJournal of Hepatology, 1995